Dermabon Psoriasis and Dandruff Soap
Dosage form: soap
Ingredients: COAL TAR 2.13g in 100g
Labeler: Jose Maria Licona Saenz
NDC Code: 49758-100
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Active Ingredients Purpose
Coal Tar 2.13 percent Anti-psoriasis, Anti-dandruff
For the relief of dandruff and psoriasis
For external use only.
Avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.
If condition worsens or does not improve after regular use of this product as directed, consult a doctor.
Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.
Do not use for prolonged periods without consulting a doctor.
Do not use this product with other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs unless directed to do so by a doctor.
If condition covers a large area of the body, consult your doctor before using this product.
Use on affected areas in place of your regular soap.
Borax, ethyl alcohol, Glycerin , Glyceryl stearate, Lanolin, Metal
Paraben, soap base, sodium hypochlorite, stearic acid , Vasoline,
vitamin E, water.
ING. JOSE MA. LICONA SAENZ
PRIVADA DE CUAUHTEMOC No.401
Product of Mexico
614 418 4085
Do not purchase if seal is brokenDERMABON
Psoriasis and Dandruff Soap
Net Weight 2.50 90.0 g
|DERMABON PSORIASIS AND DANDRUFF SOAP
coal tar soap
|Labeler - Jose Maria Licona Saenz (588895946)|
|Registrant - Jose Maria Licona Saenz (588895946)|
|Jose Maria Licona Saenz||588895946||manufacture|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.